A government panel Wednesday approved the world’s first clinical research using human induced pluripotent stem (iPS) cells, which can grow into any type of human body tissue, officials said.
The governmental scientific research institute Riken and the Foundation for Biomedical Research and Innovation won the approval from the panel at the health ministry for their clinical research plan to use iPS cells for retinal regeneration.
The research may start this year after official approval by the minister of health, labor and welfare.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.